PRIVIA HEALTH GROUP INC

Insider trading at Privia Health Group shows routine Rule 10b‑5‑1 activity—David Mountcastle sells 600 shares at $27.57, keeping confidence high and price impact minimal.

Insider buying at $2/ share and selling at $26+ shows PHG’s disciplined Rule 10b5‑1 plan – confidence in growth, not opportunistic trading.

Insider trades at Privia Health Group show bullish confidence: large Rule 10b5‑1 buys at $2 and sells near $25, highlighting upside potential and short‑term volatility for investors.

Privia Health insider trades reveal systematic buying low, selling high patterns, indicating long‑term confidence but short‑term volatility from option roll‑offs.

Insider buying surge at Privia Health: CFO’s Rule 10b5‑1 strategy shows confidence in low‑price upside, signaling a potential rally for investors.

Privia Health insider trades reveal a disciplined 10b5‑1 plan: buying low at $2, selling high at ~$25, while options sales raise dilution concerns. Investors get a clearer view of insider confidence and potential future price triggers.

Insider sales at Privia Health Group hint at a possible valuation reset amid rising analyst targets—find out what it means for investors.

Privia Health CFO’s $2.00 buy signals insider confidence – learn what the 10b5‑1 trade means for the stock’s future and investor strategy.